TP53 and breast cancer: Based on the above information, we further evidenced that gp96 degraded p53 proteins instead of its mRNA in BC, and the promoting effects of gp96 overexpression on paclitaxel-resistance were abrogated by upregulating p53, which were in consistent with the previous publications (46, 50, 51).